Pete Dodd BA (Cantab), MMath (Cantab), BSc (Open), PhD (London)
HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA
Office: 2004
Tel: (+44) (0) 114 222 0740
Fax: (+44) (0)114 222 0749
Email: p.j.dodd@sheffield.ac.uk
ORCiD: 0000-0001-5825-9347
Biography
I am a research associate in health economic modelling at ScHARR, University of Sheffield, UK, which I joined in 2013. I originally studied mathematics at Girton College, Cambridge before doing my PhD in theoretical physics at Imperial College London. I also have an Open degree from the OU for which I mainly studied biological subjects. After my PhD, I worked on infectious disease modelling as a post-doc at Imperial College London, and then at the London School of Hygiene and Tropical Medicine.
Research interests
- Infectious disease modelling.
- The epidemiology of TB, particularly in settings with high-HIV prevalence, and population-level TB interventions.
- TB in children.
- Individual-based modelling methodologies.
- Methods for model calibration and uncertainty analysis.
Teaching interests
I teach on the HEDM masters course.
Professional activities
I am a member of the Operational Research Society and the Royal Society of Tropical Medicine and Hygiene.
Projects
- Developing an user-friendly transmission and economic model for TB diagnostics (with David Dowdy & Jeff Pennington)
- Modelling the transmission of hepatitis B in among PWID in the UK, and assessing the cost-effectiveness of contingency management for vaccination (with Rachid Rafia and Alan Brennan)
- Modelling the burden of paediatric TB (with James Seddon)
- Markov modelling of HF and COPD HES records for health economic models of telemonitoring (with Praveen Thokala, Alan Brennan and Simon Dixon)
- Modelling community interventions for TB in high-HIV prevalence settings (with Gwen Knight and Richard White)
Journal articles
- Dodd PJ, Prendergast AJ, Beecroft C, Kampmann B & Seddon JA (2017) The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.. Thorax. View this article in WRRO
- Houben RM & Dodd PJ (2016) The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.. PLoS Med, 13(10), e1002152-e1002152. View this article in WRRO
- Dodd PJ, Sismanidis C & Seddon JA (2016) Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infectious Diseases, 16(10), 1193-1201. View this article in WRRO
- Dodd PJ, Looker C, Plumb ID, Bond V, Schaap A, Shanaube K, Muyoyeta M, Vynnycky E, Godfrey-Faussett P, Corbett EL, Beyers N, Ayles H & White RG (2016) Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.. Am J Epidemiol, 183(2), 156-166. View this article in WRRO
- Dodd PJ, Gardiner E, Coghlan R & Seddon JA (2014) Burden of childhood tuberculosis in 22 high-burden countries: A mathematical modelling study. The Lancet Global Health, 2(8).
- Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, Fraser C, Gopalappa C, Hallett TB, Salomon JA, Stover J, White RG & Dodd PJ (2014) The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS (London, England), 28 Suppl 1, S25-34.
- Dodd PJ, White RG & Corbett EL (2011) Periodic active case finding for TB: when to look?. PLoS One, 6, e29130-e29130. View this article in WRRO
- Dodd PJ, White PJ & Garnett GP (2010) Notions of synergy for combinations of interventions against infectious diseases in heterogeneously mixing populations. Mathematical Biosciences, 227, 94-104.
- Dodd PJ, Millington KA, Ghani AC, Mutsvangwa J, Butterworth AE, Lalvani A & Corbett EL (2010) Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity. American Journal of Epidemiology, 171, 1037-1045. View this article in WRRO
- Dodd PJ, Garnett GP & Hallett TB (2010) Examining the promise of HIV elimination by ’test and treat’ in hyperendemic settings. AIDS (London, England), 24, 729-735.